Focus: Olympus is a public medical device and imaging company headquartered in Center Valley, PA, specializing in surgical products and diagnostic imaging across oncology, gastroenterology, respiratory, and women's health. With 201-500 employees, it operates as a mid-scale player in the medical technology space.
Profile data last refreshed 14h ago · AI intelligence enriched 2mo ago
Consider Olympus for mid-career stability in medical device innovation, but verify current hiring status and cash position before committing to applications.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Olympus
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Olympus's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
8-K Filing: Gemini Space Station, Inc. (GEMI) (CIK 0002055592) — EX-99.2
EX-99.2
8-K Filing: AMN HEALTHCARE SERVICES INC (AMN) (CIK 0001142750) — 8-K
8-K
8-K Filing: VERTEX PHARMACEUTICALS INC / MA (VRTX) (CIK 0000875320) — EX-99.1
EX-99.1
8-K Filing: SPX Technologies, Inc. (SPXC) (CIK 0000088205) — EX-99.1
EX-99.1
8-K Filing: Csquare, Inc. (CSQR) (CIK 0002105398) — FORM 8-K
FORM 8-K
8-K Filing: Lazard, Inc. (LAZ) (CIK 0001311370) — EX-99.1
EX-99.1
Showing 6 of 10 news items
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Corrigendum to "Fate and transport of viruses, bacteria and antimicrobial resistance associated with wet wipes and microplastics through wastewater treatment to coastal waters" [Water Research (2026) /126281].
Fate and transport of viruses, bacteria and antimicrobial resistance associated with wet wipes and microplastics through wastewater treatment to coastal waters.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo